Mukesh Prasad was appointed Director of Cantor Equity Partners IV, Inc., effective August 25, 2026. As of November 6, 2026, Cantor Equity Partners IV, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on August 25, 2026, naming 1 appointment (Form 8-K, August 25, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Cantor Equity Partners IV, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Cantor Equity Partners IV, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-08-25. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Cantor Equity Partners IV, Inc. files it.
Also on the record for Cantor Equity Partners IV, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G/A, by Harraden Circle Investments, LLC | 8.14% of the class | 5%+ stakes | Source |
| May 14, 2026 | Stake report, Schedule 13G/A, by Harraden Circle Investments, LLC | 6.83% of the class | 5%+ stakes | Source |
| February 4, 2026 | Stake report, Schedule 13G, by Harraden Circle Investments, LLC | 5.16% of the class | 5%+ stakes | Source |
| October 6, 2025 | Stake report, Schedule 13D/A, by Cantor EP Holdings IV, LLC | 21.3% of the class | 5%+ stakes | Source |
| October 6, 2025 | Stake report, Schedule 13D/A, by LUTNICK HOWARD W | — | 5%+ stakes | Source |
| August 22, 2025 | Stake report, Schedule 13D, by Cantor EP Holdings IV, LLC | 21.3% of the class | 5%+ stakes | Source |
| August 21, 2025 | IPO filing, Form 424B4 | $10 a share | IPO filings | Source |
| August 8, 2025 | IPO filing, Form S-1/A | — | IPO filings | Source |
| July 18, 2025 | IPO filing, Form S-1 | — | IPO filings | Source |
Selling to them or working with them? See who runs Cantor Equity Partners IV, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Cantor Equity Partners IV, Inc. and the records around it.
Cantor Equity Partners IV, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- LUTNICK HOWARD W also filed stake reports on 8 other companies: BGC Group, Inc. (Oct 2025), Cantor Equity Partners, Inc. (Oct 2025), Cantor Equity Partners I, Inc. (Oct 2025)
- Harraden Circle Investments, LLC also filed stake reports on 95 other companies: Calisa Acquisition Corp (Nov 2026), Texas Ventures Acquisition III Corp (Nov 2026), Columbus Acquisition Corp (Oct 2026)
Watch Cantor Equity Partners IV, Inc.
Get an email when Cantor Equity Partners IV, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Cantor Equity Partners IV, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cantor Equity Partners IV, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cantor Equity Partners IV, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-25 | In | Director | 2026-08-25 | 8-K, 2026-08-25 |
Who leads Cantor Equity Partners IV, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Mukesh Prasad, appointed, effective 2026-08-25 (filed 2026-08-25).
New leaders reset buying decisions — get the Full Report on Cantor Equity Partners IV, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Cantor Equity Partners IV, Inc., with the record behind each one.
Find candidates like Director at Cantor Equity Partners IV, Inc.Every change, in the filing's words
Appointed: Mukesh Prasad, Director, effective 2026-08-25
Effective August 25, 2026, the board of directors (the "Board") of Cantor Equity Partners IV, Inc. (the "Company") appointed Dr. Mukesh Prasad as a member of the Board.
- Dr. Prasad will serve as a Class I director.
- Additionally, effective August 25, 2026, the Board appointed Dr. Prasad as a member of the audit committee of the Board and a member of the compensation committee of the Board.
- Dr. Prasad, age 55, is an accomplished executive with comprehensive experience in finance, investing and medicine.
- Since 2014, Dr. Prasad has served as Founder and Co-Managing Partner of Innova Capital Partners ("Innova"), a private global investment firm with a strategy predicated on identifying disruptive innovations.
- Dr. Prasad is responsible for the strategic growth and capital resources for Innova.
- Dr. Prasad is also an Otolaryngologist at Weill Cornell Medical College, where he has practiced and served as Associate Professor of Clinical Otolaryngology and Head and Neck Surgery since 2002.
- Dr. Prasad also served on the institution's Operating Board, Finance Committee, and as Chair of the Weill Cornell General Faculty Council from 2016 to 2018.
- Dr. Prasad has also served as a director of Cantor Equity Partners V, Inc. since November 2025.
- Dr. Prasad previously served as a director of Cantor Equity Partners II, Inc. from May 2026 until consummation of its initial business combination with Securitize, Inc. in July 2026.
- Dr. Prasad obtained his bachelor's degree, with honors, in Government from Harvard College, with a focus on Economic and Social Policies.
Tools for this story
Each opens in a new tab, filled in for Cantor Equity Partners IV, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.